{"id":30120,"date":"2023-06-20T11:52:24","date_gmt":"2023-06-20T11:52:24","guid":{"rendered":"https:\/\/celonpharma.com\/?p=30120"},"modified":"2023-06-20T11:52:25","modified_gmt":"2023-06-20T11:52:25","slug":"current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/","title":{"rendered":"Current report No. 11\/2023 \u2013 Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Date prepared: June 6, 2023<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Abbreviated name of the issuer: CELON PHARMA S.A.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Subject: Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Legal basis: Article 19 section 3 of the Market Abuse Regulation (MAR) \u2013 information on transactions conducted by persons discharging managerial responsibilities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Content of the report:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Management Board of Celon Pharma S.A. (the \u201cCompany\u201d) hereby informs that on June 5, 2022, it received a notification from a person discharging managerial responsibilities in the Company \u2013 Ms Dorota Zwoli\u0144ska \u2013 on her acquisition, under the Incentive Program for Members of the Management Board, of C-series shares of the Company issued under a conditional share capital increase in exchange for A-series warrants.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Company attaches the notification in question.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Date prepared: June 6, 2023 Abbreviated name of the issuer: CELON PHARMA S.A. Subject: Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities Legal basis: Article 19 section 3 of the Market Abuse Regulation (MAR) \u2013 information on transactions conducted by persons discharging managerial responsibilities. Content of<a class=\"excerpt-read-more float-right\" href=\"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/\" title=\"ReadCurrent report No. 11\/2023 \u2013 Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":31,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[46],"tags":[],"class_list":["post-30120","post","type-post","status-publish","format-standard","hentry","category-current-reports"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Current report No. 11\/2023 \u2013 Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Current report No. 11\/2023 \u2013 Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"Date prepared: June 6, 2023 Abbreviated name of the issuer: CELON PHARMA S.A. Subject: Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities Legal basis: Article 19 section 3 of the Market Abuse Regulation (MAR) \u2013 information on transactions conducted by persons discharging managerial responsibilities. Content ofRead more &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-20T11:52:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-20T11:52:25+00:00\" \/>\n<meta name=\"author\" content=\"Paulina Dobies\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paulina Dobies\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\\\/\"},\"author\":{\"name\":\"Paulina Dobies\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/e86806fa37010f6a01f6fc388950174b\"},\"headline\":\"Current report No. 11\\\/2023 \u2013 Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities\",\"datePublished\":\"2023-06-20T11:52:24+00:00\",\"dateModified\":\"2023-06-20T11:52:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\\\/\"},\"wordCount\":145,\"articleSection\":[\"Current reports\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\\\/\",\"name\":\"Current report No. 11\\\/2023 \u2013 Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"datePublished\":\"2023-06-20T11:52:24+00:00\",\"dateModified\":\"2023-06-20T11:52:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/e86806fa37010f6a01f6fc388950174b\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Current report No. 11\\\/2023 \u2013 Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/e86806fa37010f6a01f6fc388950174b\",\"name\":\"Paulina Dobies\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Current report No. 11\/2023 \u2013 Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/","og_locale":"en_US","og_type":"article","og_title":"Current report No. 11\/2023 \u2013 Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities - Celon Pharma","og_description":"Date prepared: June 6, 2023 Abbreviated name of the issuer: CELON PHARMA S.A. Subject: Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities Legal basis: Article 19 section 3 of the Market Abuse Regulation (MAR) \u2013 information on transactions conducted by persons discharging managerial responsibilities. Content ofRead more &raquo;","og_url":"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/","og_site_name":"Celon Pharma","article_published_time":"2023-06-20T11:52:24+00:00","article_modified_time":"2023-06-20T11:52:25+00:00","author":"Paulina Dobies","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Paulina Dobies","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/"},"author":{"name":"Paulina Dobies","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/e86806fa37010f6a01f6fc388950174b"},"headline":"Current report No. 11\/2023 \u2013 Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities","datePublished":"2023-06-20T11:52:24+00:00","dateModified":"2023-06-20T11:52:25+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/"},"wordCount":145,"articleSection":["Current reports"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/","url":"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/","name":"Current report No. 11\/2023 \u2013 Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"datePublished":"2023-06-20T11:52:24+00:00","dateModified":"2023-06-20T11:52:25+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/e86806fa37010f6a01f6fc388950174b"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/current-report-no-11-2023-notification-on-the-acquisition-of-c-series-shares-of-celon-pharma-s-a-by-a-person-discharging-managerial-responsibilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Current report No. 11\/2023 \u2013 Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/e86806fa37010f6a01f6fc388950174b","name":"Paulina Dobies"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/30120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=30120"}],"version-history":[{"count":1,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/30120\/revisions"}],"predecessor-version":[{"id":30121,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/30120\/revisions\/30121"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=30120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=30120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=30120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}